↓ Skip to main content

Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab …

Overview of attention for article published in Frontiers in oncology, February 2024
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
4 Mendeley